股市必读：皓宸医疗（002622）预计2025年全年营业收入6.5亿元至7.5亿元

Key Points - The core viewpoint of the article is that Haocen Medical (002622) is facing significant financial challenges, with projected losses for 2025 due to increased competition and rising customer acquisition costs in the dental service market [1][3]. Trading Information Summary - On January 30, Haocen Medical closed at 3.08 yuan, up 1.32%, with a turnover rate of 2.24%, a trading volume of 188,100 shares, and a transaction amount of 57.4874 million yuan [1]. - The net inflow of main funds was 1.5021 million yuan, while retail investors saw a net inflow of 2.5788 million yuan, and speculative funds experienced a net outflow of 4.0809 million yuan [3]. Performance Disclosure Highlights - Haocen Medical forecasts a net profit loss of 70 million to 140 million yuan for the year 2025, with a non-recurring net profit loss of 65 million to 130 million yuan [1][3]. - The expected operating revenue for 2025 is projected to be between 650 million yuan and 750 million yuan [1][3]. Company Announcement Summary - The anticipated losses are attributed to intensified competition in the dental service sector, increased customer acquisition costs, and a decline in average transaction value, leading to a decrease in profits [1][3]. - The company plans to recognize impairment provisions for goodwill and long-term equity investments, indicating a further deterioration in financial health [1][3].